Transactions UK

Law360 UK Transactions delivers daily news, real-time alerts and forward-thinking analysis on corporate transactions trends and deals in the U.K. and EU including hostile takeovers, friendly mergers, IPOs, buyouts and shareholder disputes – and the laws and regulation surrounding them.

This essential newswire is a daily must-read for successful transactions lawyers to keep up with the latest deals and dealmakers, make informed business decisions and capitalize on opportunities as they unfold.



Sign up for a 7-day FREE trial today!



Latest News in Transactions UK

  • April 12, 2024

    EU Approves Biotech Co. Illumina's Plan To Divest Grail

    European Union antitrust authorities on Friday approved Illumina's plan to sell off Grail, the latest development in a saga that saw the biotech company reverse course and agree to offload the cancer-screening company after authorities claimed the reacquisition was completed "unlawfully."

  • April 12, 2024

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen footwear brand Dr. Martens hit online retailer Temu with a passing off claim, Welsh soccer club Swansea sue its former head coach Russell Martin, Russian diamond tycoon Dmitry Tsvetkov file a claim against his former business Equix Group Ltd., and U.S. bank Omega Financial Corporation hit African oil and gas company Tende Energy with a claim. Here, Law360 looks at these and other new claims in the U.K.

  • April 12, 2024

    Abbott Loses Bid To Nix UK Whistleblowing Case On Appeal

    An appeals tribunal has rejected Abbott Laboratories' bid to escape a whistleblowing case brought by the founders of a British DNA technology business that it bought, concluding on Friday that the founders had an arguable case that U.K. judges had jurisdiction.

  • April 12, 2024

    French Bioscience Biz Raises €3M For New Drug Trials

    NFL Biosciences said Friday it had successfully raised approximately €3.1 million ($3.3 million) by issuing shares to investors to raise cash for new drug trials.

  • April 12, 2024

    SocGen To Sell Moroccan Units To Investment Firm For €745M

    Societe Generale SA said on Friday that it has agreed to sell its Moroccan banking and insurance businesses to private investor Saham Group SA for €745 million ($794 million) as part of its long-term ambition to streamline the company.

See more Transactions UK news

Intellectual Property

Areas of Coverage

  • MERGERS, ACQUISITIONS & DISPOSALS:
  • Share swaps & cash acquisitions
  • IPOs, Cash Calls and Buybacks
  • Management buy-outs and buy-ins
  • Leveraged-buyouts
  • Shareholder agreements & Poison Pills
  • Activist shareholders and proxy fights
  • Venture capital and private equity deals
  • Distressed M&A: insolvency, restructuring, bailouts
  • AGENCIES
  • The Competition and Markets Authority
  • The Financial Conduct Authority
  • The Pension Regulator
  • POLICY & REGULATION
  • U.K. Takeover Code under the Companies Act
  • Financial Services and Markets Act
  • Market Abuse Regulation
  • The Enterprise Act

Readership

  • M&A lawyers
  • Commercial disputes lawyers at top law firms
  • Executives and attorneys at insurance companies and corporate policyholders
  • Corporate counsel and compliance officers at Fortune 1000 and FTSE 350 companies
  • Information experts at law firms, agencies and companies
  • Judges and court staff across the U.K.
  • Attorney and law firm marketing professionals
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!